Correlation Engine 2.0
Clear Search sequence regions

Equilibrative nucleoside transporters (ENTs) are integral membrane proteins that facilitate the movement of nucleosides and hydrophilic nucleoside analog (NA) drugs across cell membranes. ENTs are also targets for cardioprotectant drugs, which block re-uptake of the purine nucleoside adenosine, thereby enhancing purinergic receptor signaling pathways. ENTs are therefore important contributors to drug bioavailability and efficacy. Despite this important clinical role, very little is known about the structure and regulation of ENTs. Biochemical and structural studies on ENT proteins have been limited by their low endogenous expression levels, hydrophobicity and labile nature. To address these issues, we developed an approach whereby tagged mammalian ENT1 protein was over-expressed in mammalian cell lines, confirmed to be functional and isolated by affinity purification to sufficient levels to be analyzed using MALDI-TOF and tandem MS mass spectrometry. This proteomic approach will allow for a more detailed analysis of the structure, function and regulation of ENTs in the future. Copyright 2010 Elsevier Inc. All rights reserved.


German Reyes, Zlatina Naydenova, Parween Abdulla, Maria Chalsev, Anita Villani, Jennifer B Rose, Naz Chaudary, Leroi DeSouza, K W Michael Siu, Imogen R Coe. Characterization of mammalian equilibrative nucleoside transporters (ENTs) by mass spectrometry. Protein expression and purification. 2010 Sep;73(1):1-9

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 20399865

View Full Text